Bowel/fecal incontinence refers to a patient’s inability to control bowel movements, which results in involuntary loss of solid or liquid stool. It is caused due to diarrhea, constipation, weaker muscle tone (that controls the opening of the anus), and chronic medical conditions (such as diabetes, multiple sclerosis, and nerve damage). The clinical devices used to manage bowel activity are called bowel management systems.
Major Growth Driving Factors:
Some of the major factors driving the growth of Bowel Management System Market are: expanding target patient population, rapidly growing geriatric population, availability of technologically advanced bowel management products, and favorable reimbursement scenario in developed countries.
Recent Developments:
# In 2018, Coloplast acquired IncoCare, a provider of continence products. This acquisition helped Coloplast expand its presence in Germany.
# In 2018, Axonics received marketing approval for its Axonics Sacral Neuromodulation System in Australia.
# In 2018, Coloplast expanded its product portfolio by introducing a new product, SenSura Mio Concave, into its SenSura Mio product line.
# In 2016, ConvaTec entered into an agreement with Vizient, Inc. According to this agreement, members of Vizient get access to ConvaTec’s stoma care, bowel management, and patient skincare products.
# In 2016, A German court affirmed ConvaTec’s patent protection on Flexi-Seal Fecal Management System and ordered the competitor to cease from placing its product (infringing patent) in the market, as well as to recall its product already sent to market and to compensate ConvaTec.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=45043428
Critical Questions the Report Answers:
# Where will all these developments take the bowel management systems market in the long term?
# What are the upcoming trends for the bowel management systems market? Which segment in the bowel management market provides the most opportunity for growth?
# Who are the leading vendors operating in the market? What are the opportunities for new market entrants in the bowel management market?
Key Players:
Some of the major players operating in the bowel management system market are Coloplast (Denmark), Medtronic (Ireland), 3M (US), B. Braun (Germany), C.R. Bard (US), Consure Medical (India), Cogentix Medical (US), Aquaflush Medical Limited (UK), Axonics Modulation Technologies (US), ConvaTec (UK), Hollister (US), MBH-International A/S (Denmark), Mederi Therapeutics Inc. (US), Welland Medical limited (UK), and Wellspect HealthCare (Sweden).
Growth Strategies Adopted by Them:
An analysis of market developments between 2015 and 2018 revealed that growth strategies such as product launches and approvals, agreements, expansions, and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the bowel management system market. Among these, product launches and approvals were the most widely adopted growth strategies
As of 2017, Coloplast (Denmark) is the key player in the global bowel management systems market. The company’s growth in the bowel management systems market is supported by its strong pipeline of products, sustained cost discipline, and adoption of new growth strategies to enhance its product portfolio based on new technologies available in the market. The company’s large share of the market was also supported by the launch of its SenSura Mio product portfolio in various important markets and the acquisitions of various regional players in the continence and ostomy market.
As of 2017, ConvaTec (UK) is among the key manufacturers of bowel management system. The company markets a comprehensive product portfolio of ostomy systems, accessories, and fecal incontinence products to address customer needs and preferences.
As of 2017, Hollister (US) holds a significant share in the global bowel management system market owing to its targeted product portfolio of bowel care products, which serves as an important factor for its future growth. The company is focusing on expanding its presence across the globe through various inorganic strategies. In May 2018, the company established a new distribution center in Oud Gastel, in the Netherlands. This new center is aimed at catering to the growing customer needs and it will help the company strengthen its presence in the European region. Thus, with the growing efforts of the company to expand its critical care segment, the company is expected to witness growth in the bowel management systems market in the coming years.
End Users:
The home care segment is estimated to register the highest growth rate in the bowel management systems market during the forecast period
The bowel management systems market is segmented, by end user, into home care and hospitals & ambulatory surgery centers. The home care segment is expected to register the highest growth rate of the bowel management systems market during the forecast period, owing to the factors such as the significant usage and growing adoption of bowel management products in home care settings, and need for device replacement on a regular basis.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=45043428
Geographical Growth Dynamics:
In 2018, Europe accounted for the largest share of the bowel management systems market
Geographically, the bowel management systems market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Europe accounted for the largest share of the market in 2018. The large share can be attributed to the significant disease (colorectal/bladder cancer & IBD) burden, favorable reimbursement scenario, and the increase in its geriatric population.
No comments:
Post a Comment